Positioning Intelligence
Short Interest Intelligence
Reported short interest, days to cover, price reaction, sector pressure, squeeze risk, bearish conviction, and where positioning is fighting the tape.
Signal Design
Not just “high short interest”
We score the latest reported short position against its own history, then compare that crowding with days to cover, price movement since the prior report, and Sharemaestro trend context. The result is a research map, not a trade recommendation.
The aim is to show where positioning is crowded, confirmed, trapped, or unwinding, so the user can build a better shortlist before doing ticker-level work.
Squeeze Radar
crowding plus price pressureBearish Conviction
shorts being confirmedPositioning Divergence
shorts versus priceCovering Confirmation
bearish trade unwindingSector Short Pressure
where crowding clustersSetup Distribution
classification mixPositioning Map
short positioning versus price reactionRadar Table
Current Short-Interest Reads
| Stock | Setup | Score | Short interest | Change | Days cover | Price reaction | Trend |
|---|---|---|---|---|---|---|---|
| GSBDGoldman Sachs BDC Inc | Positioning Divergence | 58 | 7.8M | +8.2% | 8.29 | +2.5% | Mixed |
| EEExcelerate Energy Inc | Positioning Divergence | 58 | 2.2M | +10.1% | 4.54 | +10.1% | Mixed |
| MDAISpectral AI Inc. | Positioning Divergence | 58 | 2.3M | -21.6% | 7.11 | -6.0% | Improving |
| NJRNewJersey Resources Corporation | Positioning Divergence | 58 | 3.7M | +39.0% | 3.31 | +4.6% | Mixed |
| NTZNatuzzi SpA | Positioning Divergence | 58 | 542 | -61.4% | 1.84 | -13.5% | Weak |
| SWIMLatham Group Inc | Neutral | 58 | 3.9M | -2.7% | 3.62 | +14.5% | Constructive |
| VBIOValion Bio Inc | Neutral | 58 | 155.2K | -40.4% | 1.00 | -1.9% | Improving |
| ASTEAstec Industries Inc | Positioning Divergence | 58 | 548.0K | +9.3% | 2.23 | +18.9% | Mixed |
| ADGMAdagio Medical Holdings, Inc Common Stock | Positioning Divergence | 58 | 60.2K | -13.8% | 1.00 | -13.3% | Weak |
| FORForestar Group Inc | Neutral | 58 | 535.0K | +4.0% | 3.29 | +9.4% | Constructive |
| JILLJ.Jill Inc | Neutral | 58 | 570.9K | +6.7% | 7.10 | +8.1% | Constructive |
| ORICOric Pharmaceuticals Inc | Positioning Divergence | 58 | 22.1M | +5.0% | 12.32 | +15.2% | Weak |
| CRVSCorvus Pharmaceuticals Inc | Positioning Divergence | 58 | 18.8M | +5.2% | 12.38 | +13.1% | Weak |
| TVRDTvardi Therapeutics, Inc. | Neutral | 58 | 507.4K | +27.5% | 1.00 | -43.2% | Improving |
| AQSTAquestive Therapeutics Inc | Neutral | 58 | 16.0M | +8.1% | 5.28 | +5.3% | Constructive |
| ALMSAlumis Inc | Positioning Divergence | 58 | 14.3M | +12.9% | 7.56 | +9.3% | Mixed |
| PGRProgressive Corp | Neutral | 58 | 7.8M | +2.0% | 1.68 | +10.5% | Constructive |
| AGCOAGCO Corporation | Positioning Divergence | 58 | 2.8M | +6.1% | 3.78 | +4.3% | Mixed |
| ALISCalisa Acquisition Corp Ordinary shares | Neutral | 58 | 876 | +37.3% | 1.00 | +0.2% | Constructive |
| WGOWinnebago Industries Inc | Positioning Divergence | 58 | 3.1M | +29.5% | 2.54 | +7.2% | Weak |
| TJGCTJGC Group Limited | Positioning Divergence | 58 | 108.6K | -12.8% | 1.00 | -16.3% | Constructive |
| NCINeo-Concept International Group Holdings Limited Ordinary Shares | Positioning Divergence | 58 | 34.5K | +41.5% | 1.00 | +4.5% | Weak |
| OLMAOlema Pharmaceuticals Inc | Positioning Divergence | 58 | 14.0M | +9.3% | 5.68 | +15.4% | Weak |
| NPKINPK International Inc. | Positioning Divergence | 58 | 2.5M | +21.3% | 1.54 | +4.2% | Mixed |
| RPRXRoyalty Pharma Plc | Neutral | 58 | 12.4M | +11.8% | 2.98 | +2.5% | Constructive |
| ALABAstera Labs, Inc. | Neutral | 58 | 12.7M | +10.1% | 1.74 | +6.7% | Constructive |
| PDLBPonce Financial Group Inc | Neutral | 58 | 313.9K | +15.9% | 2.95 | +1.8% | Constructive |
| AUPHAurinia Pharmaceuticals Inc | Neutral | 58 | 9.6M | +3.6% | 3.88 | +8.9% | Constructive |
| LOOPLoop Industries Inc | Neutral | 58 | 416.8K | +8.0% | 4.86 | -12.7% | Weak |
| NVXNovonix Ltd ADR | Neutral | 58 | 4.1M | +2.4% | 9.36 | -34.9% | Weak |
Short interest is delayed, reported twice monthly, and shown for educational research only. It does not prove buyer or seller intent, and it is not financial advice.